Alice I. Nichols - Concepedia

Author

Alice I. Nichols

Also Known As

A I Nichols, A NICHOLS, A Nichols, A. Nichols, A.I. Nichols, AW Nichols, Alice I Nichols, Alice I. Nichols, Alice Nichols, Alice Nichols I

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University at Buffalo, State University of New York Uniformed Services University of the Health Sciences Women's Health Research Institute University of California, San Francisco

About

Alice I. Nichols is an author at Pfizer (United States) specializing in pharmacology, medicine, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	605
2	Endocrinology	1	1	42
3	Hepatology	1	1	21
4	Immunology	1	1	17
5	Neurology	1	1	166

Alice I. Nichols

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease Ronald S. Black, Reisa A. Sperling, Beth Safirstein, Alzheimer Disease & Associated Disorders Bapineuzumab InfusionNeurochemical BiomarkersPharmacotherapyHumanized Monoclonal AntibodyAlzheimer's Disease	2010	166
Extended least squares nonlinear regression: A possible solution to the “choice of weights” problem in analysis of individual pharmacokinetic data Carl C. Peck, Stuart L. Beal, Lewis B. Sheiner, Journal of Pharmacokinetics and Biopharmaceutics Pharmacokinetic ModelingPossible SolutionMedicineWeights ” ProblemPharmacology	1984	159
Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression Sheldon Preskorn, Cecelia P. Kane, Kasia Lobello, The Journal of Clinical Psychiatry	2013	108
Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine Kasia Lobello, Sheldon Preskorn, Christine J. Guico‐Pabia, The Journal of Clinical Psychiatry	2010	106
Comparison of the Pharmacokinetics of Venlafaxine Extended Release and Desvenlafaxine in Extensive and Poor Cytochrome P450 2D6 Metabolizers Sheldon Preskorn, Albena Patroneva, H. Silman, Journal of Clinical Psychopharmacology	2009	78
The Problem of Choosing Weights in Nonlinear Regression Analysis of Pharmacokinetic Data Carl C. Peck, Lewis B. Sheiner, Alice I. Nichols Drug Metabolism Reviews Pharmacokinetic ModelingMedicineNonlinear Regression AnalysisRegression AnalysisPharmacology	1984	69
Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers Alice I. Nichols, Kristen Focht, Qin Jiang, Clinical Drug Investigation Molecular PharmacologyPharmacological StudyMedicineDesvenlafaxine 50Healthy Cyp2d6 Extensive	2011	63
Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units Seilesh Kadambari, Paul T. Heath, Mike Sharland, Journal of Antimicrobial Chemotherapy	2011	52
An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects Albena Patroneva, Sandra M. Connolly, Penny Fatato, Drug Metabolism and Disposition	2008	52
Venlafaxine Metabolism as a Marker of Cytochrome P450 Enzyme 2D6 Metabolizer Status Alice I. Nichols, Kasia Lobello, Christine J. Guico‐Pabia, Journal of Clinical Psychopharmacology	2009	49

Page 1